NetApp Free cash flow increased by 247.4% to $271.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 19.8%, from $338.00M to $271.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 3.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $521.00M | $191.00M | $252.00M | $199.00M | $343.00M | $216.00M | $137.00M | $319.00M | $196.00M | $418.00M | $97.00M | $448.00M | $567.00M | $300.00M | $60.00M | $338.00M | $640.00M | $620.00M | $78.00M | $271.00M |
| QoQ Change | — | -63.3% | +31.9% | -21.0% | +72.4% | -37.0% | -36.6% | +132.8% | -38.6% | +113.3% | -76.8% | +361.9% | +26.6% | -47.1% | -80.0% | +463.3% | +89.3% | -3.1% | -87.4% | +247.4% |
| YoY Change | — | — | — | — | -34.2% | +13.1% | -45.6% | +60.3% | -42.9% | +93.5% | -29.2% | +40.4% | +189.3% | -28.2% | -38.1% | -24.6% | +12.9% | +106.7% | +30.0% | -19.8% |